Pathological Insights into Neurodegenerative Diseases: Identifying Early Markers for Alzheimer's and Parkinson's

Abstract

Neurodegenerative diseases, particularly Alzheimer's and Parkinson's diseases, represent a

significant global health concern due to their debilitating effects on cognitive and motor

functions. The progressive nature of these disorders leads to a decline in the quality of life,

and as populations age, the prevalence of these diseases continues to rise. Identifying early

biomarkers is essential for timely diagnosis, intervention, and potential therapeutic

approaches. This paper explores the pathological mechanisms underlying Alzheimer's and

Parkinson's diseases, emphasizing the identification of early markers for these conditions.

Advancements in neuroimaging, biomarker discovery, and molecular pathology provide

promising avenues for early detection, which could substantially alter the course of treatment.

The discussion highlights the current state of research and the challenges faced in developing

reliable biomarkers.